Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaoru Murakami

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
BJUI Compass|September 10, 2025
Development of a novel risk model to predict CRPC progression following IMRT: Implications for tailoring treatment intensityTakashi Ogata, Rihito Aizawa, Hiroyasu Abe, et al.
Biomaterials|September 25, 2009
Hydrogel blends of chitin/chitosan, fucoidan and alginate as healing-impaired wound dressingsKaoru Murakami, Hiroshi Aoki, Shingo Nakamura, et al.
Journal of Clinical Virology Plus|September 19, 2022
SARS-CoV-2 Omicron detection by antigen tests using salivaKaoru Murakami, Sumio Iwasaki, Satoshi Oguri, et al.
Hinyokika Kiyo. Acta Urologica Japonica|July 9, 2014
[Perioperative agranulocytosis induced by immunosuppressants in a renal graft recipient : a case report]Keiyu Matsumoto, Takashi Kobayashi, Kaoru Murakami, et al.
Hinyokika Kiyo. Acta Urologica Japonica|June 4, 2026
[DEVELOPMENT OF FATAL IMMUNE CHECKPOINT INHIBITOR-ASSOCIATED ENCEPHALITIS FOLLOWING COMBINATION THERAPY WITH PEMBROLIZUMAB AND LENVATINIB IN A PATIENT WITH CLEAR CELL RENAL CELL CARCINOMA]Daisuke Takahashi, Kimihiko Masui, Hajime Takamori, et al.
JCO Precision Oncology|January 6, 2025
Clinical Utility of Serial Circulating Tumor DNA Analysis as a Minimally Invasive Biomarker in Advanced Urothelial CancerToru Sakatani, Takayuki Sumiyoshi, Yuki Kita, et al.
The American Journal of Pathology|April 28, 2020
Trp53 Mutation in Keratin 5 (Krt5)-Expressing Basal Cells Facilitates the Development of Basal Squamous-Like Invasive Bladder Cancer in the Chemical Carcinogenesis of Mouse BladderNorihiko Masuda, Kaoru Murakami, Yuki Kita, et al.
IJU Case Reports|August 4, 2020
Bladder urothelial carcinoma producing insulin-like growth factor II: A case reportSatoshi Funada, Yuki Kita, Yoshiyuki Okada, et al.
International Journal of Molecular Sciences|January 11, 2024
MRI/RNA-Seq-Based Radiogenomics and Artificial Intelligence for More Accurate Staging of Muscle-Invasive Bladder CancerTouseef Ahmad Qureshi, Xingyu Chen, Yibin Xie, et al.
Experimental and Molecular Pathology|March 17, 2026
Development and validation of a tumor-derived CXCL1 qPCR assay to support patient selection for anti-CXCL1 therapeutics in bladder cancerToru Sakatani, Sunao Tanaka, Kaoru Murakami, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
BJUI Compass|September 10, 2025
Development of a novel risk model to predict CRPC progression following IMRT: Implications for tailoring treatment intensityTakashi Ogata, Rihito Aizawa, Hiroyasu Abe, et al.
Biomaterials|September 25, 2009
Hydrogel blends of chitin/chitosan, fucoidan and alginate as healing-impaired wound dressingsKaoru Murakami, Hiroshi Aoki, Shingo Nakamura, et al.
Journal of Clinical Virology Plus|September 19, 2022
SARS-CoV-2 Omicron detection by antigen tests using salivaKaoru Murakami, Sumio Iwasaki, Satoshi Oguri, et al.
Hinyokika Kiyo. Acta Urologica Japonica|July 9, 2014
[Perioperative agranulocytosis induced by immunosuppressants in a renal graft recipient : a case report]Keiyu Matsumoto, Takashi Kobayashi, Kaoru Murakami, et al.
Hinyokika Kiyo. Acta Urologica Japonica|June 4, 2026
[DEVELOPMENT OF FATAL IMMUNE CHECKPOINT INHIBITOR-ASSOCIATED ENCEPHALITIS FOLLOWING COMBINATION THERAPY WITH PEMBROLIZUMAB AND LENVATINIB IN A PATIENT WITH CLEAR CELL RENAL CELL CARCINOMA]Daisuke Takahashi, Kimihiko Masui, Hajime Takamori, et al.
JCO Precision Oncology|January 6, 2025
Clinical Utility of Serial Circulating Tumor DNA Analysis as a Minimally Invasive Biomarker in Advanced Urothelial CancerToru Sakatani, Takayuki Sumiyoshi, Yuki Kita, et al.
The American Journal of Pathology|April 28, 2020
Trp53 Mutation in Keratin 5 (Krt5)-Expressing Basal Cells Facilitates the Development of Basal Squamous-Like Invasive Bladder Cancer in the Chemical Carcinogenesis of Mouse BladderNorihiko Masuda, Kaoru Murakami, Yuki Kita, et al.
IJU Case Reports|August 4, 2020
Bladder urothelial carcinoma producing insulin-like growth factor II: A case reportSatoshi Funada, Yuki Kita, Yoshiyuki Okada, et al.
International Journal of Molecular Sciences|January 11, 2024
MRI/RNA-Seq-Based Radiogenomics and Artificial Intelligence for More Accurate Staging of Muscle-Invasive Bladder CancerTouseef Ahmad Qureshi, Xingyu Chen, Yibin Xie, et al.
Experimental and Molecular Pathology|March 17, 2026
Development and validation of a tumor-derived CXCL1 qPCR assay to support patient selection for anti-CXCL1 therapeutics in bladder cancerToru Sakatani, Sunao Tanaka, Kaoru Murakami, et al.
Pageof 9